Back to News
Research

Dr. Wookjin Choi's Team Wins Quantum Computing Innovation Award

August 10, 2024

Dr. Wookjin Choi

Department of Radiation Oncology, Thomas Jefferson University

Dr. Wookjin Choi, Assistant Professor in the Department of Radiation Oncology at Sidney Kimmel Medical College at Thomas Jefferson University, has achieved a significant milestone in the field of quantum computing for healthcare.

Quantum Computing Innovation Lab

Dr. Choi has been selected to participate in the National Cancer Institute's (NCI) Quantum Computing Innovation Lab, a prestigious program bringing together leading researchers to explore the potential of quantum computing in cancer research and treatment.

Top Prize for Team Quantum Heart

Team Quantum Heart, co-led by Dr. Choi, was one of three teams to receive the top prize of $25,000 in the quantum computing innovation competition. The project seeks to revolutionize the existing clinical decision-making framework by leveraging the unique strengths of quantum computing to predict and prevent cardiotoxicity in cancer patients.

Collaborative Excellence

Dr. Choi collaborated with an exceptional team of researchers from leading institutions:

  • - **Iman Borazjani, PhD** (Texas A&M University) - Team Leader
  • **Wookjin Choi, PhD** (Sidney Kimmel Medical College at Thomas Jefferson University)
  • **Jiaqi (Jimmy) Leng, PhD** (University of California, Berkeley)
  • **Zhenhua Jiang, PhD** (University of Dayton Research Institute)

Impact and Vision

"It was a privilege to collaborate with this exceptional team," said Dr. Choi. "Our diverse expertise in medical physics, artificial intelligence, fluid simulations, and quantum algorithms allowed us to develop a concept we believe can make a real-world impact on patient care. This prize is not just an award; it's the fuel that will help us propel our research forward."

The Quantum Heart project represents a pioneering effort to apply quantum computing's immense processing power to solve complex medical problems that are currently computationally intractable with classical computers. By predicting cardiotoxicity risk more accurately, the team aims to help oncologists and cardiologists make better treatment decisions that maximize cancer treatment effectiveness while minimizing heart damage.

This achievement underscores Thomas Jefferson University's commitment to cutting-edge research at the intersection of physics, computer science, and medicine, positioning the institution at the forefront of quantum computing applications in healthcare.